Breaking News

Symeres Earns ISO/IEC 27001 Certification

Reinforces its proactive commitment to safeguarding sensitive client data across its global operations.

Author Image

By: Charlie Sternberg

Associate Editor

Symeres has been awarded ISO/IEC 27001 certification, the internationally recognized standard for information security management systems (ISMS). This certification reinforces the company’s proactive commitment to safeguarding sensitive client data across its global operations.

“Cybersecurity is no longer a back-office issue; it is central to the success of every client program,” said Gabriella Gentile, Chief Operating Officer at Symeres. “Our ISO 27001 certification gives clients, from biotech startups to large pharmaceutical companies, the assurance that their proprietary data, often the ‘crown jewels’ of development, is protected within a robust and continuously improving security framework.”

While Symeres has long operated with strong internal protocols, the decision to pursue formal certification arose from a rising volume of security questionnaires from clients, financial institutions, and regulators.

For many large pharmaceutical companies, information security assessments are now a standard part of onboarding. ISO 27001 certification allows Symeres to address the majority of these requirements upfront, significantly streamlining due diligence processes. By reducing administrative friction, project teams can focus more quickly on what matters most: advancing client programs and delivering scientific impact.

Guillaume Jetten, CEO at Symeres, said: “In today’s environment, ISO 27001 is a non-negotiable foundation for doing business with large pharmaceutical companies and innovative biotechs. Achieving this certification cements Symeres’ status as a leading global CDMO operating with full transparency and accountability.”

With ISO 27001 in place, Symeres is positioned to support the needs of both established pharmaceutical clients and smaller biotechs that may rely on its expertise to navigate complex data governance. The certification also supports broader industry compliance efforts, including the EU’s NIS2 Directive, which identifies healthcare organizations as vital operators.

Symeres is progressing with the rollout of ISO 27001 certification across its sites globally, with completion targeted before the end of the year. This phased implementation ensures consistent standards across the Group while maintaining operational continuity.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters